The Worrying Murkiness of Institutional Biosafety Committees
Experts say institutional biosafety committees are a crucial to ensuring the safety of biomedical research. Critics say they are too opaque.
Stay updated with breaking news from Daniel Eisenman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts say institutional biosafety committees are a crucial to ensuring the safety of biomedical research. Critics say they are too opaque.
Experts say IBCs are a crucial tool for ensuring the safety of biomedical research. Critics say they are too opaque.
In this report, key developments are highlighted in the field with a focus on biosafety and provides guidance for performing risk assessments on...
02.17.21 -- Why Did Veeva Become A Public Benefit Corporation? With the spread of SARS-CoV-2 (COVID-19) intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring life-saving drugs to market. Attend this webinar to learn more about bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy and the impacts and comparisons of classic platforms vs. new-generation platforms. And more! By Ed Miseta, chief editor, Clinical Leader On February 1, 2021, Veeva Systems o...